Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on May 6, 2025
Zevra Therapeutics Announces Details for Q1 2025 Financial Results Call
GlobeNewswire
·
May 6, 2025
CELEBRATION, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it will report corporate …
Bioventus Reports First Quarter Financial Results
GlobeNewswire
·
May 6, 2025
Q1 reported revenue of $123.9 million declined 4.3%; Organic* revenue advanced 5.0% First quarter net loss was $0.04 per share compared to a loss of $0.08 in the prior-year period Non-GAAP earnings* of $0.08 per share increased 33% Company reiterated …
Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway
GlobeNewswire
·
May 6, 2025
ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it has successfully completed its March/April spider silk …
Y-mAbs to Announce First Quarter 2025 Financial and Operating Results on May 13, 2025
GlobeNewswire
·
May 6, 2025
PRINCETON, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody- …
The Joint Corp. Strengthens Management Appointing SVP Legal and SVP Operations and Patient Experience
GlobeNewswire
·
May 6, 2025
- Franchising legal specialist Andra J. Terrell with 20 years of experience in global master, single-unit and multi-unit franchising; compliance strategy; and financing, mergers, acquisitions, and divestitures- - Franchise operations leader Eric Wyatt with …
Pasithea Therapeutics Reports Positive Pharmacodynamic Results Demonstrating Robust Target Engagement from its Ongoing Phase 1 Clinical Trial of PAS-004
GlobeNewswire
·
May 6, 2025
-- PAS-004 shows up to 91% inhibition of pERK, confirming substantial target engagement -- -- One patient in cohort 4A with stage 4 KRAS G12R mutated pancreatic cancer achieves over 5 months of stable disease with tumor volume reduction of -9.8% -- MIAMI, …
EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025
GlobeNewswire
·
May 6, 2025
EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025 EBX-102-02 was well tolerated and demonstrated clinically meaningful improvements across multiple symptom domains in IBS-C patients Ph2b trial in IBS-C initiating in H2 2025 to …
MADD Canada’s Campaign 911 Urges People to Report Suspected Impaired Drivers, Riders and Boaters
GlobeNewswire
·
May 6, 2025
OAKVILLE, Ontario, May 06, 2025 (GLOBE NEWSWIRE) -- An impaired driver is an emergency. That’s the powerful message at the heart of MADD Canada’s Campaign 911, the national awareness program launching today to encourage Canadians to call 911 and report …
La Campagne 911 de MADD Canada exhorte les gens à signaler les conducteurs d’auto, de VTT et de bateau dont les capacités semblent affaiblies
GlobeNewswire
·
May 6, 2025
OAKVILLE, Ontario, 06 mai 2025 (GLOBE NEWSWIRE) -- Les conducteurs aux capacités affaiblies sont des situations d’urgence. C’est le puissant message au cœur de la Campagne 911 de MADD Canada, le programme de sensibilisation nationale, lancé aujourd’hui …
Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference
GlobeNewswire
·
May 6, 2025
BURLINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced it …
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 6, 2025
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in the following May investor conferences: BofA Securities 2025 Healthcare Conference: Fireside chat on Tuesday, …
Blue Point Brewing Co. Announces the Return of Delayed Pilsner
GlobeNewswire
·
May 6, 2025
PATCHOGUE, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Blue Point Brewing Co., a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) craft beer brand, announces the highly anticipated re-release of Delayed Pilsner, a beer crafted to soothe the soul of every New …
TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 6, 2025
Updates from the PLEXI-T™ solid tumor and ALLOHA™ heme Phase 1 clinical trials anticipated by end of year On-track to file IND application for TSC-102-A0301 (CD45; HLA-A*03:01) to FDA in the second half of the year Appointed commercial leader Stephen …
Vantage Hemp Co. Submits Application for Brazil Market Entry
GlobeNewswire
·
May 6, 2025
Greeley, Colorado, May 06, 2025 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or “the Company”), a globally accredited cannabinoid extractor and manufacturer, has initiated its regulatory process with ANVISA, Brazil’s National Health Surveillance Agency, …
Transpire Bio Announces R&D and Manufacturing Expansion
GlobeNewswire
·
May 6, 2025
SUNRISE, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has signed an agreement to expand …
Advanced Aesthetics Plastic Surgery Partners with Ascend Aesthetic Partners to Strengthen a Collaborative Community Focused on Growth, Learning, and Patient Care
GlobeNewswire
·
May 6, 2025
ATLANTA, May 06, 2025 (GLOBE NEWSWIRE) -- Advanced Aesthetics Plastic Surgery has joined Ascend Aesthetic Partners, forming a partnership rooted in shared values of collaboration, clinical excellence, and continuous learning. With the addition of Dr. …
Sharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ Syringes
GlobeNewswire
·
May 6, 2025
Sharps also received an initial qualification purchase order for DisGard™ single-use Sharps Recovery System Company transitions to revenue producing with second purchase order, bringing total recent orders to approximately $500,000 for the quarter NEW YORK …
Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025
GlobeNewswire
·
May 6, 2025
Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona” or the “Company”), a …
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE
GlobeNewswire
·
May 6, 2025
KUALA LUMPUR, MALAYSIA, May 06, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”) today announced that it entered into an Exchange Agreement with FITTERS Diversified Berhad (9318.KL; “FITTERS …
Mind Lab PRO Under Review: Is Mind Lab Pro® v4.0 Universal Nootropic Brain Booster Safe? Best Nootropics Supplement
GlobeNewswire
·
May 6, 2025
Royal Leamington Spa, May 06, 2025 (GLOBE NEWSWIRE) -- Mind Lab Pro is a nootropic pill containing relatively high concentrations of eleven distinct nootropic substances. It promises to help the following: Focus Energy Mood’s Calmness Memory Clarity …